Stephanie Harel - Publications

Outcomes of patients with Waldenström macroglobulinemia in ICU: a retrospective multicentric study.

Journal: Journal of critical care

Published: July 01, 2026

Hospital at Home for BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A Multicenter Real-World Feasibility and Safety Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 07, 2026

Improved survival in patients admitted to ICU with multiple myeloma: a retrospective cohort analysis.

Journal: Annals of intensive care

Published: April 21, 2026

CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma.

Journal: HemaSphere

Published: November 28, 2025

Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain Amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: November 21, 2025

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.

Journal: EJHaem

Published: October 16, 2025

Gamma heavy chain disease treated with daratumumab-based regimen: a first case report and review of literature.

Journal: Immunotherapy

Published: August 21, 2025

Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 09, 2025

Molecular profiling and risk stratification in solitary bone plasmacytoma.

Journal: Leukemia

Published: March 02, 2025

Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome.

Journal: Haematologica

Published: February 18, 2025

Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients.

Journal: Journal of medical virology

Published: January 27, 2025

Immunosubstitution of patients with refractory multiple myeloma treated with teclistamab, a bispecific antibody

Journal: Annales pharmaceutiques francaises

Published: December 17, 2024